| 2025 | 2024 | 2023 | 2022 | 2021 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 190,1 M € | +8.8% | 174,8 M € | -11.1% | 196,6 M € | -0.2% | 196,9 M € | +7.1% | 183,9 M € | +57.2% | 116,9 M € | -2.2% | 119,6 M € | +8.8% | 109,9 M € | -5.5% | 116,3 M € | +12.6% | 103,2 M € | +12.4% | 91,9 M € | +16.4% | 78,9 M € | |
| EBITDA | 56,3 M € | +18.3% | 47,6 M € | -19.5% | 59,1 M € | -16.2% | 70,5 M € | +6.6% | 66,2 M € | +87.7% | 35,2 M € | -8.3% | 38,4 M € | +19.8% | 32,1 M € | -10.9% | 36,0 M € | +48.7% | 24,2 M € | +31.4% | 18,4 M € | +18.0% | 15,6 M € | |
| Operating profit | 43,8 M € | +25.5% | 34,9 M € | -24.7% | 46,4 M € | -20.5% | 58,3 M € | +5.3% | 55,4 M € | +108.8% | 26,5 M € | -7.1% | 28,6 M € | +25.6% | 22,7 M € | -13.2% | 26,2 M € | +69.7% | 15,4 M € | +50.9% | 10,2 M € | +39.2% | 7,3 M € | |
| Profit/loss | 53,7 M € | +163.3% | -84,8 M € | -315.0% | 39,4 M € | -9.2% | 43,4 M € | +3.4% | 42,0 M € | +78.5% | 23,5 M € | -11.1% | 26,5 M € | +34.4% | 19,7 M € | +9.3% | 18,0 M € | +78.1% | 10,1 M € | -19.0% | 12,5 M € | +92.7% | 6,5 M € | |
| Equity | 73,7 M € | +22.5% | 60,1 M € | -58.4% | 144,7 M € | -0.5% | 145,3 M € | -3.2% | 150,2 M € | +214.8% | 47,7 M € | -3.2% | 49,3 M € | +25.8% | 39,2 M € | +1.4% | 38,6 M € | +17.0% | 33,0 M € | +4.3% | 31,6 M € | +63.7% | 19,3 M € | |
| Total assets | 212,4 M € | +2.8% | 206,6 M € | -20.1% | 258,4 M € | -2.9% | 266,1 M € | +20.6% | 220,5 M € | +2.5% | 215,1 M € | +4.7% | 205,4 M € | +3.6% | 198,2 M € | -3.0% | 204,4 M € | +1.3% | 201,7 M € | -0.9% | 203,5 M € | +3.9% | 195,9 M € | |
| Cash | 2,5 M € | +83.5% | 1,4 M € | -28.8% | 1,9 M € | -15.1% | 2,3 M € | -48.8% | 4,4 M € | +189.6% | 1,5 M € | -40.0% | 2,6 M € | +25.9% | 2,0 M € | +44.2% | 1,4 M € | -13.8% | 1,6 M € | +16.5% | 1,4 M € | +5.4% | 1,3 M € | |
| Debts | 133,9 M € | -5.8% | 142,2 M € | +28.1% | 111,0 M € | -6.1% | 118,2 M € | +86.4% | 63,4 M € | -61.7% | 165,6 M € | +7.2% | 154,5 M € | -1.8% | 157,3 M € | -4.1% | 164,0 M € | -2.0% | 167,4 M € | -1.9% | 170,6 M € | -2.7% | 175,4 M € | |
| Staff | 665,6 | 676,9 | 704 | 702 | 667,2 | 488 | 490,5 | 500,1 | 502,8 | 480,5 | 495,6 | 470,5 | ||||||||||||
Public limited company · Alken · incorporated on 16/08/1989 · 665,6 ETP
Public limited company profitable and well capitalised. Cash position rising (+83.5%).
Solid counterparty for a standard engagement.
| Unit no. | Name | Location |
|---|---|---|
| 2044875509 | — | Kolmenstraat 1519, 3570 Alken |
DATWYLER PHARMA PACKAGING BELGIUM is a Public limited company incorporated in 1989. Its main activity is: Fabrication d’autres articles en caoutchouc. Its registered office is in Alken. It employs on average 665,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette